本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

5.27
+0.11002.13%
成交量:46.60万
成交额:241.58万
市值:3.60亿
市盈率:-2.39
高:5.29
开:5.13
低:5.06
收:5.16
数据加载中...
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/04

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/06

重要事件披露

Form 8-K - Current report
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]